StockData
Korsana Biosciences, Inc. logo

Korsana Biosciences, Inc. (KRSA) stock

KRSANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30493% above fair value
$32.50−0.18 (-0.55%)

Close on Nov 17, 2026Market cap $152.14MP/E –Yield –

Korsana Biosciences operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Korsana Biosciences's operating cash flow for the twelve months ending Jun 30, 2026 was -$4.45M. For fiscal 2025 it was -$3.31M. The highest annual figure on record is -$3.31M in fiscal 2025.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$3.31M–
FY2024Dec 31, 2024-$4.33M–
FY2023Dec 31, 2023-$21.25M–
FY2022Dec 31, 2022-$40.61M–
FY2021Dec 31, 2021-$36.52M–
FY2020Dec 31, 2020-$72.49M–
FY2019Dec 31, 2019-$102.22M–
FY2018Dec 31, 2018-$97.50M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$1.43M–
Q1 FY2026Mar 31, 2026-$1.18M–
Q4 FY2025Dec 31, 2025-$1.58M-538.6%
Q3 FY2025Sep 30, 2025-$264.00K–
Q2 FY2025Jun 30, 2025-$503.00K–
Q1 FY2025Mar 31, 2025-$968.00K–
Q4 FY2024Dec 31, 2024$360.00K–
Q3 FY2024Sep 30, 2024-$1.72M–
Q2 FY2024Jun 30, 2024-$1.11M–
Q1 FY2024Mar 31, 2024-$1.87M–
Q4 FY2023Dec 31, 2023-$1.54M–
Q3 FY2023Sep 30, 2023-$6.94M–
Q2 FY2023Jun 30, 2023-$6.56M–
Q1 FY2023Mar 31, 2023-$6.21M–
Q4 FY2022Dec 31, 2022-$7.04M–
Q3 FY2022Sep 30, 2022-$9.92M–
Q2 FY2022Jun 30, 2022-$10.82M–
Q1 FY2022Mar 31, 2022-$12.84M–
Q4 FY2021Dec 31, 2021-$8.63M–
Q3 FY2021Sep 30, 2021-$7.92M–
Q2 FY2021Jun 30, 2021-$5.51M–
Q1 FY2021Mar 31, 2021-$14.46M–
Q4 FY2020Dec 31, 2020-$14.04M–
Q3 FY2020Sep 30, 2020-$15.05M–
Q2 FY2020Jun 30, 2020-$14.22M–
Q1 FY2020Mar 31, 2020-$29.18M–
Q4 FY2019Dec 31, 2019-$22.16M–
Q3 FY2019Sep 30, 2019-$23.81M–
Q2 FY2019Jun 30, 2019-$21.97M–
Q1 FY2019Mar 31, 2019-$34.27M–
Q4 FY2018Dec 31, 2018-$23.15M–
Q3 FY2018Sep 30, 2018-$25.30M–
Q2 FY2018Jun 30, 2018-$22.62M–
Q1 FY2018Mar 31, 2018-$26.43M–

More Korsana Biosciences figures

See a number that looks wrong?